>>Cardiome Pharma Corp. announces exercise of over-allotment option
Monday January 22, 9:00 am ET
NASDAQ: CRME TSX: COM
VANCOUVER, Jan. 22 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that the underwriters of its cross-border public offering of 8,000,000 common shares that was priced on January 18, 2007, exercised the over-allotment option in full to purchase an additional 1,200,000 common shares at a price of US$10.50 per share. Net proceeds from the offering (including the common shares to be issued pursuant to the exercise of the over-allotment option) are expected to be approximately US$90 million.
Bear, Stearns & Co. Inc. acted as book-running manager, CIBC World Markets Inc. acted as co-lead manager and Canaccord Adams Inc. and Leerink Swann & Company acted as co-managers for the offering. Raymond James Ltd., Orion Securities Inc. and Sprott Securities Inc. were also part of the underwriting syndicate.
The offering is expected to close on or about January 23, 2007, subject to customary conditions.<<
snip
I didn't get filled on a lowball bid for shares after the offering was first announced, and my sold puts expired . . . so, no position, but looking for yet another entry.
Cheers, Tuck |
